TradingKey

關於 MiMedx Group Inc 公司

MiMedx Group, Inc. 是一家胎盤生物製劑公司。該公司致力於開發和分銷具有專利保護工藝的胎盤組織異體移植，服務於醫療保健的多個領域。其產品組合類別包括傷口護理產品以及外科和其他產品。其傷口護理產品包括 EPIFIX、EPICORD 和 EPIEFFECT，這些產品均用於外用，例如用於高級傷口護理應用。其外科和其他產品包括 AMNIOFIX、AMNIOCORD 和 AMNIOEFFECT，這些產品適用於各種應用和外科環境，包括下肢修復、整形外科、血管外科和多種骨科修復和重建。該公司的平臺技術包括源自人胎盤膜的組織異體移植、源自人臍帶的組織異體移植以及源自人胎盤的顆粒細胞外基質。

公司簡介

公司代碼MDXG

公司名稱MiMedx Group Inc

上市日期Aug 20, 2007

CEOMr. Joseph H. (Joe) Capper

員工數量837

證券類型Ordinary Share

年結日Aug 20

公司地址1775 W Oak Commons Court, Ne

城市MARIETTA

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編30062

電話17706519100

網址https://mimedx.com/

公司代碼MDXG

上市日期Aug 20, 2007

CEOMr. Joseph H. (Joe) Capper

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph H. (Joe) Capper

Chief Executive Officer, Director

529.53K

+60.69%

Mr. James L. Bierman

Independent Director

212.77K

+15.53%

Ms. Ricci S. Whitlow

Executive Vice President, Chief Operating Officer

190.25K

-57.15%

Dr. Cato T. Laurencin, M.D., Ph.D.

Independent Director

181.92K

+18.66%

Ms. Kimberly (Kim) Maersk-Moller

Chief Commercial Officer

89.04K

--

Ms. Dorothy E. Puhy

Independent Director

57.60K

+98.69%

Mr. William A. (Bill) Hawkins, III

Independent Director

--

Mr. Douglas C. Rice

Chief Financial Officer

--

Mr. K. Todd Newton

Independent Director

--

Dr. M. Kathleen Behrens Wilsey, Ph.D.

Independent Chairman of the Board

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph H. (Joe) Capper

Chief Executive Officer, Director

529.53K

+60.69%

Mr. James L. Bierman

Independent Director

212.77K

+15.53%

Ms. Ricci S. Whitlow

Executive Vice President, Chief Operating Officer

190.25K

-57.15%

Dr. Cato T. Laurencin, M.D., Ph.D.

Independent Director

181.92K

+18.66%

Ms. Kimberly (Kim) Maersk-Moller

Chief Commercial Officer

89.04K

--

Ms. Dorothy E. Puhy

Independent Director

57.60K

+98.69%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

業務USD

名稱

營收

佔比

Advanced Wound Care

56.07M

63.57%

Surgical

32.13M

36.43%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

Advanced Wound Care

56.07M

63.57%

Surgical

32.13M

36.43%

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

EW Healthcare Partners

19.06%

BlackRock Institutional Trust Company, N.A.

5.80%

Trigran Investments, Inc.

5.14%

The Vanguard Group, Inc.

4.52%

Paradigm Capital Management, Inc.

3.17%

Other

62.33%

持股股東

佔比

EW Healthcare Partners

19.06%

BlackRock Institutional Trust Company, N.A.

5.80%

Trigran Investments, Inc.

5.14%

The Vanguard Group, Inc.

4.52%

Paradigm Capital Management, Inc.

3.17%

Other

62.33%

股東類型

持股股東

佔比

Venture Capital

19.09%

Investment Advisor/Hedge Fund

18.48%

Investment Advisor

18.17%

Hedge Fund

11.43%

Research Firm

2.06%

Individual Investor

1.84%

Pension Fund

0.46%

Bank and Trust

0.39%

Sovereign Wealth Fund

0.28%

Other

27.81%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

450

106.68M

72.20%

-3.42M

2025Q1

460

106.92M

72.40%

-5.30M

2024Q4

455

107.57M

73.21%

-3.01M

2024Q3

429

103.18M

70.48%

-6.90M

2024Q2

424

100.59M

68.44%

-3.52M

2024Q1

405

106.53M

74.65%

+1.42M

2023Q4

391

100.91M

86.85%

+27.80M

2023Q3

385

72.00M

62.20%

-22.83M

2023Q2

375

65.55M

56.85%

-21.21M

2023Q1

361

82.89M

72.72%

-885.21K

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

EW Healthcare Partners

28.20M

19.09%

--

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

8.58M

5.81%

+179.59K

+2.14%

Mar 31, 2025

Trigran Investments, Inc.

7.60M

5.15%

-21.96K

-0.29%

Mar 31, 2025

The Vanguard Group, Inc.

6.69M

4.53%

+5.46K

+0.08%

Mar 31, 2025

Paradigm Capital Management, Inc.

4.68M

3.17%

-2.73K

-0.06%

Mar 31, 2025

State Street Global Advisors (US)

3.46M

2.34%

+189.21K

+5.79%

Mar 31, 2025

First Light Asset Management, LLC

3.45M

2.34%

+109.21K

+3.27%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.91M

1.97%

+133.11K

+4.79%

Mar 31, 2025

Cannell Capital, LLC

2.13M

1.44%

-1.51M

-41.39%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

2.01M

1.36%

+206.79K

+11.47%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Invesco NASDAQ Future Gen 200 ETF

0.43%

First Trust Small Cap Growth AlphaDEX Fund

0.26%

ALPS Barron's 400 ETF

0.18%

iShares Micro-Cap ETF

0.16%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.14%

WisdomTree US SmallCap Quality Growth Fund

0.13%

Franklin US Small Cap Multifactor Index ETF

0.12%

VictoryShares Small Cap Free Cash Flow ETF

0.1%

SPDR S&P Biotech ETF

0.1%

First Trust Small Cap Core Alphadex Fund

0.1%

Invesco NASDAQ Future Gen 200 ETF

佔比0.43%

First Trust Small Cap Growth AlphaDEX Fund

佔比0.26%

ALPS Barron's 400 ETF

佔比0.18%

iShares Micro-Cap ETF

佔比0.16%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.14%

WisdomTree US SmallCap Quality Growth Fund

佔比0.13%

Franklin US Small Cap Multifactor Index ETF

佔比0.12%

VictoryShares Small Cap Free Cash Flow ETF

佔比0.1%

SPDR S&P Biotech ETF

佔比0.1%

First Trust Small Cap Core Alphadex Fund

佔比0.1%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

MiMedx Group Inc

7.160USD

MiMedx Group Inc

7.160

概覽

公司

財務